Hematologic neoplasms are a heterogeneous group of cancers comprising several subgroups of neoplasms. So far, despite major epidemiological concerns about quality of care, limited data are available for patients with hematologic malignancies. To retrospectively analyze the epidemiological, clinical and hematological characteristics of patients at the Hospital Universitário de Vassouras, Rio de Janeiro, Brazil during the COVID-19 pandemic. In addition, it aims to report the most prevalent hematological diseases in the municipality. In addition, it is important to consider that patients with hematological malignancy are immunocompromised. It is expected that the present study will reveal that there is an increased risk of serious events related to COVID-19 (ICU admission, need for MV or death) in patients with hematologic malignancy compared to patients infected with COVID-19 without cancer. due to the high vulnerability of patients with hematological malignancies in the current pandemic. It was observed that there is an increased risk of serious events related to COVID-19 (ICU admission, need for MV or death) in patients with hematologic malignancy compared to patients infected with COVID-19 without cancer due to the high vulnerability of the patients. patients with hematologic malignancies in the current pandemic. It was therefore noted that clinicians must pay close attention to treating COVID-19 patients with hematologic malignancy. Telephone screening or other online technologies must be used to verify the need for treatment or follow-up at inpatient or outpatient clinics. In non-lifethreatening patients, hospitalization must be postponed. Patients with fever or other symptoms that may be related to COVID-19 must be tested for SARS-CoV-2 RNA and they must not be accepted into the hematology ward before the possibility of COVID-19 has

Introduction:Metabolic improvement results not only from weight loss and reduced insulin resistance, but also from changes in digestive hormones (especially incretins) that help improve insulin secretion. This paradigm shift, evolving from bariatric surgery to metabolic surgery, opens new perspectives. Materials and Methods: The present work was bibliographic research, with the main objective of describing the nursing record in auditing. A survey was carried out in the Google Scholar and SciELO and Lilacs databases. Observing publications in Portuguese, Spanish and English. Results: This article will consider the development of innovative surgical techniques aimed at endocrine-metabolic improvement rather than weight loss, the surgical treatment of type 2 diabetic patients with body mass index. Discussion: Numerous randomized clinical trials, although mostly short/medium term, demonstrate that metabolic surgery achieves excellent glycemic control. Final considerations: Although additional studies are needed to demonstrate long-term benefits, there is sufficient clinical and mechanistic evidence to support the inclusion of metabolic surgery among anti-diabetes interventions for people with T2DM and obesity.

Annually, the number of patients on hemodialysis in Brazil and in the world grows, mainly with the increasing number of cases of Arterial Hypertension, Diabetes and Obesity, resulting from the demographic transition. Avoiding the catheter is the obvious best strategy to reduce episodes of bloodstream infection. Interventions such as early referral of patients to nephrologists, multidisciplinary teams, and vascular access coordinators who provide patient education; implantation of arteriovenous grafts for early cannulation for hemodialysis; and urgent-onset peritoneal dialysis have been shown to be effective in decreasing catheter use. New interventions for prophylaxis of catheter-associated bloodstream infection include the following:(1) clear chlorhexidine-impregnated exit site dressing; (2) a chlorhexidine coated stem hub device; and (3) an antimicrobial, preferably antibiotic-free, lock. There may be an important and underused role for S. aureus nasal decolonization protocols with mupirocin for hemodialysis patients. A combination of these interventions may be ideal. Finally, identifying barriers to safe practices in the hemodialysis setting, using human factors systems engineering, will undoubtedly prove invaluable in reducing infections in the future.

In less than a year, the SARS-CoV-2 pandemic has become responsible for more than 2 million deaths worldwide, leading to the disruption of all health systems and economic disasters. There is now clear evidence that severe obesity is a significant risk factor for mortality. Patients are generally healthier after metabolic surgery, which can result in a less severe form of SARS-CoV-2 infection and a better prognosis after contracting this disease. To test this hypothesis, the present study was designed to determine the association of previous metabolic surgery with the severity of SARS-CoV-2 infection in severely obese patients. Non-systematic literature review study in the Medline scientific database focusing on the association between previous metabolic surgery and COVID-19 severity in obese patients. The findings of this review of 7 observational studies in patients with a history of prior bariatric surgery indicate that a history of bariatric surgery is associated with lower rates of hospitalization and mortality in obese patients after SARS-CoV-2 infection. The present study revealed that findings from observational studies suggest that prior bariatric surgery is associated with a lower rate of mortality and hospital admission in obese patients who become infected with SARS-CoV-2. Confirmation of these findings will require larger studies with better quality data.

Engenharia -Educação. 2. Engenharia de produção. 3.Planejamento estratégico. I. Título. CDD 658.5 Elaborado por Maurício Amormino Júnior -CRB6/2422 O conteúdo dos artigos e seus dados em sua forma, correção e confiabilidade são de responsabilidade exclusiva dos autores. 2018 Permitido o download da obra e o compartilhamento desde que sejam atribuídos créditos aos autores, mas sem a possibilidade de alterá-la de nenhuma forma ou utilizá-la para fins comerciais.